ACADIA Pharmaceuticals Inc. which can be found using ticker (ACAD) have now 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between 33 and 12 calculating the average target price we see $22.98. Given that the stocks previous close was at $24.31 this would indicate that there is a downside of -5.5%. Also worth taking note is the 50 day moving average now sits at $20.17 while the 200 day moving average is $17.80. The company has a market capitalization of 4.03B. The stock price for Skyline Champion Corporation is 24.8 USD
The potential market cap would be $3,812,448,904 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 3.21 and a -16.04% return on assets.
